Skip to main content
. 2019 Mar 12;14(1):7–19. doi: 10.5009/gnl18203

Fig. 7.

Fig. 7

Mechanism of action of tumor necrosis factor (TNF) inhibitors.

MAPK, mitogen-activated protein kinase; JNK, c-Jun N terminal kinase; IKK, inhibitor of kappa B kinase; IκB, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor; NF-κB, nuclear facor-κB; AP-1, activator protein- 1; MLKL, mixed lineage kinase domain-like protein. Modified from Nakase H. To master the optimal therapy for ulcerative colitis. Tokyo: Igakutokangosha Co., Ltd., 2018, with permission.2